1 active not recruiting, 1 recruiting, 1 withdrawn. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Active not recruiting 1, Recruiting 1, Withdrawn 1 |
Follow B Lymphoblastic Lymphoma: new trials by email Literature Review of B Lymphoblastic Lymphoma trials Research Report on B Lymphoblastic Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparing Inotuzumab Combined With Low Intensity Chemotherapy Plus Blinatumomab to Usual Chemotherapy Plus Blinatumomab in Older Adults With CD22+ B-cell Acute Lymphoblastic Leukemia Cyclophosphamide, Vincristine, Dexamethasone - B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma | Phase 2 | Active not recruiting | Alliance for Clinical Trials in Oncology | 68 | 2023-06-09 | 2026-07-10 |
| Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride With Asparaginase in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma Asparaginase, Cyclophosphamide, Doxorubicin Hydrochloride - B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma | Phase 2 | Withdrawn | University of Washington | 2018-07-01 | 2018-11-14 | |
| Blinatumomab, Inotuzumab Ozogamicin, and Combination Chemotherapy as Frontline Therapy in Treating Patients With B Acute Lymphoblastic Leukemia Blinatumomab, Cyclophosphamide, Cytarabine - B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma | Phase 2 | Recruiting | M.D. Anderson Cancer Center | 80 | 2016-11-01 | 2026-05-20 |
Burkitt Lymphoma (3) · Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (3) · Lymphoma (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1) · Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (1)
DNA Virus Infections (3) · Epstein-Barr Virus Infections (3) · Hematologic Diseases (3) · Hemic and Lymphatic Diseases (3) · Herpesviridae Infections (3) · Immune System Diseases (3) · Immunoproliferative Disorders (3) · Infections (3) · Leukemia (3) · Leukemia, Lymphoid (3) · Lymphatic Diseases (3) · Lymphoma, B-Cell (3) · Lymphoma, Non-Hodgkin (3) · Lymphoproliferative Disorders (3) · Neoplasms (3)
Cyclophosphamide (3) · Doxorubicin (3) · Prednisone (3) · Rituximab (3) · Vincristine (3) · Cytarabine (2) · Dexamethasone (2) · Inotuzumab Ozogamicin (2) · Mercaptopurine (2) · Methotrexate (2) · deltacortene (2) · prednylidene (2) · Asparaginase (1) · CT-P10 (1) · Calcium Dobesilate (1)
Alliance for Clinical Trials in Oncology (1) · M.D. Anderson Cancer Center (1) · University of Washington (1)
United States (3) · Puerto Rico (1)
Elias Jabbour (1) · Marlise R. Luskin, MD, MSCE (1) · Ryan Cassaday (1)
PMID 41671463, PMID 33191168, PMID 35622074, PMID 36279879
P30CA015704 (1), U10CA180821 (1)